Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ESH 2017 | Game-changing treatments for leukemia

Ravi Majeti • 12 Oct 2017
ESH 2017
Leukemia

This is an exciting time for leukemia treatment, with multiple new therapies being approved and various agents on the horizon. At the International Conference of Acute Myeloid Leukaemia 2017 in Estoril, Portugal by the European School of Hematology (ESH), Ravindra Majeti, MD, PhD, from Stanford University, Stanford, CA, discusses why he is enthusiastic about novel treatments against leukemia and details the improvements required to move this treatment forwards.

More from Ravi Majeti

Using gene editing to model clonal hematopoiesis
1:06
Using gene editing to model clonal hematopoiesis
Ravi Majeti • 6 Dec 2024
The detection and management of clonal hematopoiesis
1:26
The detection and management of clonal hematopoiesis
Ravi Majeti • 6 Dec 2024
Investigating mutation order in AML using single-cell sequencing
2:05
Investigating mutation order in AML using single-cell sequencing
Ravi Majeti • 8 Apr 2024
Developing LSC-targeting agents in AML: progress and current therapeutic capacity
0:59
Developing LSC-targeting agents in AML: progress and current therapeutic capacity
Ravi Majeti • 8 Apr 2024

Related Videos

Unmet needs in CLL genomics: heterogeneity and clinical impact
1:11
Unmet needs in CLL genomics: heterogeneity and clinical impact
Elias Campo • 16 Oct 2026
Insights into key topics most likely to impact day-to-day CLL management
1:40
Insights into key topics most likely to impact day-to-day CLL management
Alessandra Ferrajoli • 16 Oct 2026
Translating current CLL evidence into national guidelines: which gaps remain?
3:33
Translating current CLL evidence into national guidelines: which gaps remain?
Mary Ann Anderson • 16 Oct 2026
Frontline management of Richter’s transformation: current approaches and remaining uncertainties
2:40
Frontline management of Richter’s transformation: current approaches and remaining uncertainties
Philip Thompson • 22 Oct 2026

Choose your cookie settings

VJHemOnc uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.

Cookie Policy (opens in a new tab)
The content of VJHemOnc is intended for healthcare professionals